Ticker
BTAI
Asset Class
Equity
Assets Under Management
45.12M
Holdings
10+
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
Loading chart…